These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16586465)

  • 21. Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based study.
    van Wijk BL; Avorn J; Solomon DH; Klungel OH; Heerdink ER; de Boer A; Brookhart AM
    J Hypertens; 2007 Mar; 25(3):689-97. PubMed ID: 17278986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    J Clin Epidemiol; 2006 Jan; 59(1):11-7. PubMed ID: 16360556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
    Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of antihypertensive drugs in three European countries.
    Nicotra F; Wettermark B; Sturkenboom MC; Parodi A; Bellocco R; Ekbom A; Merlino L; Leimanis A; Mancia G; Fored M; Corrao G
    J Hypertens; 2009 Sep; 27(9):1917-22. PubMed ID: 19506527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
    Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
    Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
    Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
    Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients.
    Wong MC; Jiang JY; Griffiths SM
    Am J Hypertens; 2009 Aug; 22(8):904-10. PubMed ID: 19478791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal analysis of antihypertensive drug interactions in a Medicaid population.
    Carter BL; Lund BC; Hayase N; Chrischilles E
    Am J Hypertens; 2004 May; 17(5 Pt 1):421-7. PubMed ID: 15110901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D; Lopez J; Meier J
    Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of life and antihypertensive therapy].
    Vajó Z; Székács B
    Orv Hetil; 1993 Nov; 134(45):2477-9. PubMed ID: 7902554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the cumulative incidences of add-on therapy among the major antihypertensive classes in 2531 Asian patients: a cohort study.
    Wong MC
    J Clin Pharm Ther; 2010 Apr; 35(2):201-5. PubMed ID: 20456739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project.
    Bøg-Hansen E; Lindblad U; Ranstam J; Melander A; Råstam L
    Pharmacoepidemiol Drug Saf; 2002; 11(1):45-54. PubMed ID: 11998551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of antihypertensives and the risk of Parkinson disease.
    Becker C; Jick SS; Meier CR
    Neurology; 2008 Apr; 70(16 Pt 2):1438-44. PubMed ID: 18256367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study.
    Wong MC; Lau RK; Jiang JY; Griffiths SM
    J Clin Pharm Ther; 2012 Jun; 37(3):335-41. PubMed ID: 22023456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.